TABLE 2.
Substrate | TEM-60
|
TEM-60 P51L
|
TEM-60 K104E (TEM-7)
|
TEM-60 S164R (TEM-18)
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kmb (μM) | kcat (s−1) | kcat/Km (μM−1 · s−1) | Km (μM) | kcat (s−1) | kcat/Km (μM−1 · s−1) | Kmb (μM) | kcat (s−1) | kcat/Km (μM−1 · s−1) | Km (μM) | kcat (s−1) | kcat/Km (μM−1 · s−1) | |
Nitrocefin | 20 | 5 | 0.25 | 180 | 8 | 0.044 | 41 (NAc) | 176 (NA) | 4.3 (NA) | 65 (NA) | 600 (NA) | 9.2 (NA) |
Cephaloridine | 28 | 15 | 0.54 | 18 | 22 | 1.2 | 70 (87) | 127 (26) | 1.8 (0.30) | 156 (321) | 590 (675) | 3.8 (2.1) |
Cefotaxime | 31 | 1.5 | 0.048 | >1,000d | <0.01e | <10−5 | >1,000d (100) | <0.01e (1.5) | <10−5 (0.015) | 210 (1,975) | 0.45 (158) | 0.002 (0.080) |
Ceftazidime | 59 | 12 | 0.20 | 80 | 60 | 0.75 | >1,000d (1,000) | <0.01e (9.0) | <10−5 (0.009) | >1,000d (2,875) | <0.01e (23) | <10−5 (0.008) |
Aztreonam | 55 | 9 | 0.16 | 660 | 17 | 0.026 | >1,000d (1,333) | <0.01e (4.0) | <10−5 (0.003) | 1,660 (785) | 150 (11) | 0.090 (0.014) |
Ampicillin | 9 | 18 | 2.0 | 450 | 3.2 | 0.007 | 4.2 (16) | <0.01e (18) | <10−5 (1.1) | 335 (35) | 146 (920) | 0.44 (26) |
Penicillin G | 9 | 26 | 2.9 | 575 | 23 | 0.040 | 1.7 (3.1) | 33 (40) | 19 (13) | 15 (20) | 200 (1,400) | 13 (69) |
Km and kcat values are the means of three measurements. The standard deviation was always lower than 5%. Data for TEM-60 are from reference 3. Data for TEM-7 (10) and for TEM-18 (10) are shown in parentheses in comparison to those of the K104E and S164R mutants.
Km values lower than 10 μM were determined as Ki as described previously (4), using nitrocefin (200 to 300 μM) as the reporter substrate.
NA, not available.
Evaluated upon exposure of the enzyme to a substrate concentration of up to 1 mM, using nitrocefin (200 μM) as the reporter substrate.
Found using an enzyme concentration of 25 nM and a substrate concentration of 1 mM and recording the absorbance for 30 min.